Diabetic Kidney Disease



A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY1142524 in Patients With Type II Diabetes and a Clinical Diagnosis of Diabetic Kidney Disease


Condition:   Diabetic Kidney Disease
Interventions:   Drug: BAY1142524;   Drug: Placebo
Sponsor:   Bayer
Not yet recruiting


SWIDINEP a Swiss Diabetic Nephropathy Cohort


Condition:   Diabetic Nephropathy
Intervention:  
Sponsor:   Centre Hospitalier Universitaire Vaudois
Recruiting


Use of Wharton Jelly in Diabetic Nephropathy


Condition:   Diabetic Nephropathies
Intervention:   Biological: Wharton Jelly Mesenchymal stem cells
Sponsors:   Sophia Al-Adwan;   Jordan University of Science and Technology;   An-Najah National University
Not yet recruiting


Effect Insulin Pump Therapy to Patients With Diabetic Nephropathy


Condition:   Insulin Pump Therapy in Treating Diabetic Nephropathy
Intervention:   Device: Insulin pump
Sponsor:   Chinese PLA General Hospital
Completed


Empaglifozin in Early Diabetic Kidney Disease


Conditions:   Diabetic Kidney Disease;   Diabetes Mellitus Type 2
Interventions:   Drug: Empagliflozin;   Other: Placebo
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting


Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease


Conditions:   Type 2 Diabetes Mellitus;   Diabetic Kidney Disease
Intervention:   Drug: Jinshuibao Capsule
Sponsor:   Second Xiangya Hospital of Central South University
Not yet recruiting


This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 5 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated


Condition:   Diabetic Nephropathies
Interventions:   Drug: BI 690517;   Drug: Eplerenone;   Drug: Placebo
Sponsor:   Boehringer Ingelheim
Recruiting


Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan


Condition:   Type 2 Diabetic Nephropathy
Interventions:   Drug: Alfacalcidol;   Drug: Irbesartan
Sponsor:   The Third Xiangya Hospital of Central South University
Recruiting


Clinical Trial of HuangKui Capsule to Treat Diabetic Kidney Disease


Condition:   Diabetic Kidney Disease
Interventions:   Drug: Placebo drug that simulates Irbesartan tablets;   Drug: irbesartan tablets;   Drug: Placebo drug that simulates HuangKui capsule;   Drug: HuangKui Capsule
Sponsor:   Jiangsu Famous Medical Technology Co., Ltd.
Recruiting


Resveratrol's Effects in Diabetic Nephropathy


Condition:   Diabetic Nephropathy
Interventions:   Drug: Resveratrol;   Drug: Placebo;   Drug: Losartan
Sponsor:   Shiraz University of Medical Sciences
Completed


NEPHSTROM for Diabetic Kidney Disease


Condition:   Diabetic Kidney Disease
Interventions:   Biological: Mesenchymal Stromal Cells;   Other: Placebo
Sponsors:   Mario Negri Institute for Pharmacological Research;   Leiden University Medical Center;   ASST Papa Giovanni XXIII, Bergamo, Italy;   IRCCS - Istituto di Ricerche Farmacologiche Mario Negri - Bergamo, Italy;   Belfast Health and Social Care Trust;   National University of Ireland, Galway, Ireland;   University Hospital Birmingham, NHS Foundation Trust, Hospital, Birmingham, UK;   NHS Blood and Transplant
Not yet recruiting


Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease


Condition:   Diabetic Kidney Disease
Interventions:   Drug: Finerenone (BAY94-8862);   Drug: Placebo
Sponsor:   Bayer
Recruiting


Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease


Condition:   Diabetic Kidney Disease
Interventions:   Drug: Finerenone (BAY94-8862);   Drug: Placebo
Sponsor:   Bayer
Recruiting


Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy


Condition:   Diabetic Nephropathy
Interventions:   Drug: MT-3995 Low;   Drug: MT-3995 Middle;   Drug: MT-3995 High;   Drug: Placebo
Sponsor:   Mitsubishi Tanabe Pharma Corporation
Completed


Colchicine for Diabetic Nephropathy Trial


Condition:   Diabetic Nephropathies
Interventions:   Drug: Colchicine;   Drug: Placebo
Sponsors:   Sheba Medical Center;   D-Cure, Israel
Recruiting


Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With Macroalbuminuria


Condition:   Diabetic Nephropathy
Interventions:   Drug: MLN1202 Placebo;   Drug: MLN1202
Sponsor:   Takeda
Withdrawn


Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout


Condition:   Diabetic Nephropathy
Interventions:   Drug: Topiroxostat BID, (Oral daily dosing for 28 weeks);   Drug: Placebo BID, (Oral daily dosing for 28 weeks)
Sponsors:   Sanwa Kagaku Kenkyusho Co., Ltd.;   Fuji Yakuhin Co., Ltd.
Completed


Study Of Diabetic Nephropathy With Atrasentan


Condition:   Diabetic Nephropathy
Interventions:   Drug: Atrasentan;   Drug: Placebo
Sponsor:   AbbVie
Active, not recruiting


Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD)


Conditions:   Diabetes;   Hypertension;   Diabetic Kidney Disease
Intervention:   Behavioral: Pharmacist telehealth intervention
Sponsor:   Duke University
Active, not recruiting


Study of LY3016859 in Participants With Diabetic Nephropathy


Condition:   Diabetic Nephropathy
Interventions:   Drug: Placebo;   Drug: LY3016859
Sponsor:   Eli Lilly and Company
Completed


Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease


Condition:   Diabetic Kidney Disease
Interventions:   Drug: BMS-813160;   Drug: Placebo matching with BMS-813160
Sponsor:   Bristol-Myers Squibb
Completed


A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease


Condition:   Diabetic Kidney Disease
Interventions:   Drug: Baricitinib;   Drug: Placebo
Sponsors:   Eli Lilly and Company;   Incyte Corporation
Completed


Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients


Condition:   Diabetic Nephropathy
Interventions:   Drug: Repository Corticotropin Injection;   Drug: Placebo
Sponsor:   Mallinckrodt
Completed


A Study in Participants With Diabetic Kidney Disease


Conditions:   Diabetic Kidney Disease;   Diabetic Nephropathy;   Diabetic Glomerulosclerosis
Interventions:   Drug: LY2382770;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Terminated


Delaying the Progression of Diabetic Nephropathy in Pima Indians


Condition:   Diabetic Nephropathy
Intervention:  
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed

Refine Your Search Advanced Search